OZEM vs. PPH ETF Comparison

Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Market Vectors Pharmaceutical ETF (PPH)

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$25.91

Average Daily Volume

37,536

Number of Holdings ^*

* may have additional holdings in another (foreign) market

PPH

Market Vectors Pharmaceutical ETF

PPH Description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Grade (RS Rating)

Last Trade

$88.58

Average Daily Volume

202,752

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	OZEM	PPH
30 Days	-7.33%	-4.99%
60 Days	-7.73%	-7.40%
90 Days	-10.10%	-9.32%
12 Months		15.09%

5 Overlapping Holdings

Symbol	Grade	Weight in OZEM	Weight in PPH	Overlap
AZN	D	3.99%	4.41%	3.99%
LLY	F	14.13%	11.57%	11.57%
NVO	D	17.04%	7.69%	7.69%
PFE	D	3.07%	4.23%	3.07%
TAK	F	2.17%	4.6%	2.17%

OZEM Overweight 9 Positions Relative to PPH

Symbol	Grade	Weight
ALT	C	4.44%
VKTX	F	3.39%
AMGN	D	3.26%
SRRK	B	2.8%
REGN	F	2.4%
RYTM	C	2.3%
TERN	F	1.97%
CORT	B	1.77%
OPK	C	1.72%

OZEM Underweight 19 Positions Relative to PPH

Symbol	Grade	Weight
JNJ	D	-6.86%
MCK	B	-6.08%
BMY	B	-5.89%
ABBV	D	-5.76%
COR	B	-5.18%
NVS	D	-5.01%
MRK	F	-4.8%
ZTS	D	-4.68%
HLN	D	-4.56%
SNY	F	-4.26%
GSK	F	-3.88%
TEVA	D	-3.65%
VTRS	A	-2.27%
CTLT	B	-1.14%
JAZZ	B	-1.11%
ELAN	D	-0.65%
OGN	D	-0.57%
PRGO	B	-0.49%
PDCO	D	-0.24%

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic